Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03386032 · ClinicalTrials.gov registry record · Phase 3
8-Week Atopic Dermatitis (AD) Treatment Study
A Phase 3 study, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 3
- Development phase
- 65
- Enrollment target
NCT03386032 is a Phase 3 study that has completed, run by Procter and Gamble. The registered enrollment target is 65 participants.
The verdict
NCT03386032, a Phase 3 study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 65 participants
- Enrollment target
Study Summary
This is a study to investigate the clinical effectiveness of the Sponsor's experimental cream treatment on eczema as measured by visual grading of SCORAD (scoring of atopic dermatitis).
Interventions
- OTHER Placebo Cream
- DRUG Investigational OTC Cream
- DRUG 0.05% Desonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2018-08-18 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03386032
The ClinicalTrials.gov registry entry for NCT03386032 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Cream is the first listed.
NCT03386032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03386032 about?
NCT03386032 is a clinical study titled "8-Week Atopic Dermatitis (AD) Treatment Study". This is a study to investigate the clinical effectiveness of the Sponsor's experimental cream treatment on eczema as measured by visual grading of SCORAD (scoring of atopic dermatitis).
What is the current status of trial NCT03386032?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 65 participants. The study started on 2017-11-27. Estimated completion is 2018-08-18.
What interventions are being tested in trial NCT03386032?
The interventions under investigation include: Placebo Cream (OTHER), Investigational OTC Cream (DRUG), 0.05% Desonide (DRUG).
Who is sponsoring clinical trial NCT03386032?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.